CorMedix competitorsClear all

CorMedix's top competitors include Alexion Pharmaceuticals, Innovation Pharmaceuticals and ASIT Biotech.
CorMedix
CorMedix
CorMedix is a pharmaceutical company that seeks to in-license, develop and commercialize therapeutic products for the treatment of cardiac and kidney disease.
Alexion Pharmaceuticals
Alexion Pharmaceuticals
Alexion is a global biopharmaceutical company focused on developing and delivering life-transforming therapies for patients with devastating and rare diseases.
Innovation Pharmaceuticals
Innovation Pharmaceuticals
Innovation Pharmaceuticals is engaged in developing therapies with oncology, dermatology and antimicrobial applications.
ASIT Biotech
ASIT Biotech
ASIT Biotech is a clinical-stage biopharmaceutical company, which focuses on the research, development, and commercialization of immunotherapy products for the treatment of allergies.
Founding Date
Founding Date
2006
Founding Date
1992
Founding Date
2007
Founding Date
1997
Type
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Watchung, US HQ
Locations
New Haven, US HQ
Buenos Aires, AR
Sydney, AU
Vienna, AT
São Paulo, BR
Toronto, CA
Prague, CZ
see more
Locations
Beverly, US HQ
Locations
Liège, BE HQ
Sint Lambrechts Woluwe, BE
Employees
Employees
2257% increase
Employees
2,6565% increase
Employees
450% decrease
Employees
2630% increase
Valuation ($)
Valuation ($)
176.2 m
Valuation ($)
26.1 b
Valuation ($)
38.9 m
Valuation ($)
N/A
Twitter followers
Twitter followers
641
Twitter followers
3.9 k
Twitter followers
197
Twitter followers
N/A
Alexa Website Rank
Alexa Website Rank
163052
Alexa Website Rank
628049
Alexa Website Rank
117073
Alexa Website Rank
N/A

Financial

Revenue (est.)
Revenue (est.)
$429.8k (FY, 2018)
Revenue (est.)
$4.1b (FY, 2018)
Revenue (est.)
N/A
Revenue (est.)
N/A
Cost of goods
Cost of goods
$396.8k (FY, 2018)
Cost of goods
$374.3m (FY, 2018)
Cost of goods
N/A
Cost of goods
N/A
Gross profit
Gross profit
$33k (FY, 2018)
Gross profit
$3.8b (FY, 2018)
Gross profit
N/A
Gross profit
N/A
Net income
Net income
($26.8m) (FY, 2018)
Net income
$77.6m (FY, 2018)
Net income
($8.7m) (FY, 2019)
Net income
N/A
For sources of this data, please see the company profile

View company profiles

Alexion Pharmaceuticals
HQ
New Haven, US
Employees
2,656↑ 5% increase

Alexion is a global biopharmaceutical company focused on developing and delivering life-transforming therapies for patients with devastating and rare diseases.

View company
Innovation Pharmaceuticals
HQ
Beverly, US
Employees
4↓ 50% decrease

Innovation Pharmaceuticals is engaged in developing therapies with oncology, dermatology and antimicrobial applications.

View company
ASIT Biotech
HQ
Liège, BE
Employees
26↑ 30% increase

ASIT Biotech is a clinical-stage biopharmaceutical company, which focuses on the research, development, and commercialization of immunotherapy products for the treatment of allergies.

View company